
Innogen grants Arcera exclusive rights to its long-acting GLP-1 receptor agonist across Africa, Eastern Europe, Latin America and the Middle East.
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
about 9 years ago
Health Policy Problem Solver: Fumie Griegoabout 9 years ago
Dealmaking in 2017: Striking a Balanceabout 9 years ago
Beyond the Science: Commercial Implications From ASCO 2017over 9 years ago
News Spotlight: Pharmaover 9 years ago
Pharma’s Marijuana Makeoverover 9 years ago
The 'Hear' and Now for Pharma and Social Mediaover 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseover 9 years ago
Syncing Social Media With Value-Care Modelover 9 years ago
AI-based Social Listening as Aid to Pharmacovigilanceover 9 years ago
Country Report: Indonesia




